Vascular targeting as a strategy for cancer therapy.
Schnitzer
J E
JE
Harvard Medical School, Boston, MA 02115, USA.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage*; D004337:Drug Carriers; D004730:Endothelium, Vascular / Q000187:drug effects; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000098:blood supply*; D010455:Peptides / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D004337:Drug Carriers; D010455:Peptides; D004317:Doxorubicin